
August 14, 2026
Alliance Medical achieves Radelumin® licensing milestone across two UK radiopharmacy facilities
Following MHRA approval, Alliance Medical’s Guildford and Dinnington radiopharmacy facilities can now commercially supply fully licensed Radelumin® across the UK, supporting dependable access to prostate cancer imaging.
Read more